Cancer News ⁽⁴⁾

On August 20, 2026, the National Medical Products Administration approved Anfuliqita Monoclonal Antibody Injection (subcutaneous injection; brand name Yisaina), a Class-1 innovative drug filed by 3SBio (Shanghai) Co., Ltd. The new drug is indicated for acute attacks of gouty arthritis in adults with contraindications, intolerance,…

According to Xinhua, the Weizmann Institute of Science in Israel recently issued a statement saying that researchers analyzed tumor samples from 11 patients with high-grade serous ovarian cancer (one of the most common and aggressive types of ovarian cancer) as well as immune cells in…

On the eve of World Cancer Day, the World Health Organization released its latest global research report, pointing out that if people avoid a range of risk factors such as smoking, alcohol consumption and air pollution, nearly 40% of cancer cases could be prevented. The…

A paper published in the latest issue of the US Journal of Neuro-Oncology reports that researchers and clinicians from the University of Nottingham and other institutions have jointly developed a rapid method for diagnosing brain tumors. This genetic diagnostic method can rapidly detect relevant human…